Ratings by Raymond James (Tiago Fauth)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/23/2026 | Benitec BioPharma | BNTC | New Coverage | Outperform (N/A) |
8.82 (8.65) |
-1.93% | Details | |
| 10/23/2026 | CAMP4 Therapeutics Corp | CAMP | New Coverage | Strong Buy (N/A) |
3.39 (3.30) |
-2.65% | Details | |
| 10/20/2026 | Rapport Therapeutics | RAPP | Maintain | Strong Buy (N/A) |
|
Details | ||
| 10/20/2026 | United Therapeutics Corp. | UTHR | Maintain | Outperform (N/A) |
|
Details | ||
| 10/20/2026 | Tonix Pharma | TNXP | Maintain | Strong Buy (N/A) |
|
Details | ||
| 10/20/2026 | PTC Therapeutics | PTCT | Maintain | Outperform (N/A) |
|
Details | ||
| 10/20/2026 | Milestone Pharmaceuticals | MIST | Maintain | Strong Buy (N/A) |
|
Details | ||
| 10/20/2026 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 10/20/2026 | Insmed | INSM | Maintain | Outperform (N/A) |
|
Details | ||
| 10/9/2026 | Quince Therapeutics Inc. | QNCX | New Coverage | Outperform (N/A) |
29.36 (31.73) |
8.07% | Details | |
| 10/2/2026 | Avalyn Pharma | AVLN | New Coverage | Outperform (N/A) |
27.42 (26.04) |
-5.03% | Details | |
| 9/25/2026 | Seaport Therapeutics | SPTX | New Coverage | Strong Buy (N/A) |
21.12 (20.61) |
-2.41% | Details | |
| 9/22/2026 | Rapport Therapeutics | RAPP | Maintain | Strong Buy (N/A) |
|
Details | ||
| 9/22/2026 | Tonix Pharma | TNXP | Maintain | Strong Buy (N/A) |
|
Details | ||
| 9/8/2026 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 8/17/2026 | Rapport Therapeutics | RAPP | Maintain | Strong Buy (N/A) |
|
Details | ||
| 8/17/2026 | Praxis Precision Medicines Inc. | PRAX | Maintain | Strong Buy (N/A) |
|
Details | ||
| 8/13/2026 | Polaryx Therapeutics | PLYX | New Coverage | Strong Buy (N/A) |
2.23 (1.85) |
-17.04% | Details | |
| 8/10/2026 | Tonix Pharma | TNXP | Maintain | Strong Buy (N/A) |
|
Details | ||
| 7/27/2026 | MapLight Therapeutics | MPLT | Maintain | Strong Buy (N/A) |
|
Details | ||
| 6/24/2026 | Tonix Pharma | TNXP | New Coverage | Strong Buy (N/A) |
11.96 (5.17) |
-56.77% | Details | |
| 6/24/2026 | MapLight Therapeutics | MPLT | New Coverage | Strong Buy (N/A) |
28.64 (7.97) |
-72.17% | Details | |
| 5/7/2026 | Rapport Therapeutics | RAPP | Maintain | Strong Buy (N/A) |
|
Details | ||
| 4/9/2026 | PTC Therapeutics | PTCT | New Coverage | Outperform (N/A) |
71.26 (60.59) |
-14.97% | Details | |
| 4/9/2026 | Praxis Precision Medicines Inc. | PRAX | New Coverage | Strong Buy (N/A) |
320.22 (252.96) |
-21% | Details | |
| 4/9/2026 | Jazz Pharmaceuticals | JAZZ | New Coverage | Outperform (N/A) |
195.93 (214.00) |
9.22% | Details | |
| 4/9/2026 | Ionis Pharmaceuticals | IONS | New Coverage | Outperform (N/A) |
74.98 (42.93) |
-42.74% | Details | |
| 4/9/2026 | Insmed | INSM | New Coverage | Outperform (N/A) |
160.18 (93.39) |
-41.7% | Details | |
| 4/9/2026 | Rapport Therapeutics | RAPP | New Coverage | Strong Buy (N/A) |
33.69 (25.93) |
-23.03% | Details | |
| 4/9/2026 | United Therapeutics Corp. | UTHR | New Coverage | Outperform (N/A) |
581.69 (587.50) |
1% | Details |
